News
Back to listing
News

New Director of MRC Oxford Institute for Radiation Oncology

24 Jan 2019

A new Director has been appointed to run the Medical Research Council Oxford Institute for Radiation Oncology (OIRO).

Professor Amato Giaccia has joined OIRO after many successful years as Director of the Division of Radiation & Cancer Biology at the University of Stanford, California. He is internationally recognised for his contribution to understanding the role of tumour microenvironment, hypoxia, and HIF-1-mediated pathways in cancer. He has more than 20 years of experience in his field of research with over 200 publications in addition to serving on a number of committees and editorial boards.

His international standing, plus his wealth of experience in the field of radiation oncology will ensure the continued success of OIRO and its close working relationships with cancer collaborators and major funding bodies. 

Dr Mariana Delfino-Machin, MRC Programme Manager for Cancer, said: "OIRO is the MRC’s major strategic investment in radiation oncology research and the appointment of Professor Giaccia provides a platform for OIRO to build upon its significant discoveries in the field. Professor Giaccia is an excellent addition to the UK’s radiation oncology community."

Professor Gavin Screaton, Head of the Medical Sciences Division, University of Oxford commented: "Amato is a fantastic catch for the Oxford oncology community and we are delighted he has chosen to join us from Stanford. He has already made his presence felt having hit the ground running and we look forward to him taking the Institute to the next level."

Categories

  • Categories: Corporate
  • Health categories: Other
  • Strategic objectives: Regulation, ethics, governance and working with decision-makers
  • Locations: Oxford
  • Type: News article